These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

225 related items for PubMed ID: 17292

  • 1. Interaction of plasma membranes with influenza virus. VII. Effect on 3',5'-cyclic adenosine monophosphate phosphodiesterase activity.
    Krizanová O, Lacinová D, Knopp J.
    Acta Virol; 1977 Mar; 21(2):97-103. PubMed ID: 17292
    [Abstract] [Full Text] [Related]

  • 2. Cyclic nucleotide phosphodiesterase activity in normal and neoplastic rat mammary cells grown in monolayer culture.
    Cohen LA, Straka D, Chan PC.
    Cancer Res; 1976 Jun; 36(6):2007-12. PubMed ID: 178439
    [Abstract] [Full Text] [Related]

  • 3. Cyclic nucleotide-mediated regulation of vascular smooth muscle cell cyclic nucleotide phosphodiesterase activity. Selective effect of cyclic AMP.
    Maurice DH.
    Cell Biochem Biophys; 1998 Jun; 29(1-2):35-47. PubMed ID: 9631237
    [Abstract] [Full Text] [Related]

  • 4. Influence of chlorpromazine on the replication of influenza virus in chick embryo cells.
    Krizanová O, Ciampor F, Veber P.
    Acta Virol; 1982 Jul; 26(4):209-16. PubMed ID: 6127927
    [Abstract] [Full Text] [Related]

  • 5. Role of calcium-dependent regulator protein (CDR) in inhibition of 3',5'-c AMP-phosphodiesterase by influenza virus. II. Kinetic studies on inhibition of CDR-dependent phosphodiesterase by influenza virus.
    Krizanová O.
    Acta Virol; 1979 Jul; 23(4):303-13. PubMed ID: 40417
    [Abstract] [Full Text] [Related]

  • 6. Activation and selective inhibition of a cyclic AMP-specific phosphodiesterase, PDE-4D3.
    Alvarez R, Sette C, Yang D, Eglen RM, Wilhelm R, Shelton ER, Conti M.
    Mol Pharmacol; 1995 Oct; 48(4):616-22. PubMed ID: 7476886
    [Abstract] [Full Text] [Related]

  • 7. Cyclic 3',5'-adenosine monophosphate phosphodiesterase (cAMP PDE) and cyclic 3',5'-guanosine monophosphate phosphodiesterase (cGMP PDE) in microvessels isolated from bovine cortex.
    Stefanovich V.
    Neurochem Res; 1979 Dec; 4(6):681-7. PubMed ID: 232543
    [Abstract] [Full Text] [Related]

  • 8. Regulation of cyclic adenosine 3':5'-monophosphate phosphodiesterases: altered pattern in transformed myoblasts.
    Seth PK, Rogers J, Narindrasorasak S, Sanwal BD.
    J Cell Physiol; 1983 Sep; 116(3):336-44. PubMed ID: 6309871
    [Abstract] [Full Text] [Related]

  • 9. Changes in specific activities of 3',5'-cyclic adenosine monophosphate phosphodiesterase in chick embryo cells grown under different conditions.
    Krizanová O, Veber P.
    Acta Virol; 1982 Sep; 26(5):328-32. PubMed ID: 6128902
    [Abstract] [Full Text] [Related]

  • 10. Cyclic 3',5'-adenosine monophosphate phosphodiesterase in the thymus of normal and leukemic mice.
    Menahan LA, Kemp RG.
    J Cyclic Nucleotide Res; 1976 Sep; 2(6):417-25. PubMed ID: 190277
    [Abstract] [Full Text] [Related]

  • 11. Characterization of 3',5' cyclic nucleotide phosphodiesterase activity in Y79 retinoblastoma cells: absence of functional PDE6.
    White JB, Thompson WJ, Pittler SJ.
    Mol Vis; 2004 Oct 06; 10():738-49. PubMed ID: 15480303
    [Abstract] [Full Text] [Related]

  • 12. Correlation of cell-free brain cyclic nucleotide phosphodiesterase activities to cyclic AMP decay in intact brain slices.
    Whalin ME, Garrett RL, Thompson WJ, Strada SJ.
    Second Messengers Phosphoproteins; 2004 Oct 06; 12(5-6):311-25. PubMed ID: 2856115
    [Abstract] [Full Text] [Related]

  • 13. Induction of apoptosis by an inhibitor of cAMP-specific PDE in malignant murine carcinoma cells overexpressing PDE activity in comparison to their nonmalignant counterparts.
    Marko D, Romanakis K, Zankl H, Fürstenberger G, Steinbauer B, Eisenbrand G.
    Cell Biochem Biophys; 1998 Oct 06; 28(2-3):75-101. PubMed ID: 9515161
    [Abstract] [Full Text] [Related]

  • 14. [Effect of radiation-protective preparations on the level of cyclic adenosine-3',5'-monophosphate (cycl AMP), adenylate cyclase and cycl AMP phosphodiesterase].
    Sobolev AS, Orekhov AN, Dhirkov IuIu, Kudriashov IuB.
    Dokl Akad Nauk SSSR; 1975 Sep 21; 224(3):713-6. PubMed ID: 173507
    [No Abstract] [Full Text] [Related]

  • 15. The effect of Ca++ on cyclic nucleotide phosphodiesterases of superior cervical ganglion.
    Boudreau RJ, Drummond GI.
    J Cyclic Nucleotide Res; 1975 Sep 21; 1(4):219-28. PubMed ID: 177462
    [Abstract] [Full Text] [Related]

  • 16. Decreased adenosine cyclic 3',5'-monophosphate phosphodiesterase activity in rat straitum following chronic haloperidol treatment.
    Fredholm BB.
    Med Biol; 1977 Feb 21; 55(1):61-5. PubMed ID: 191703
    [Abstract] [Full Text] [Related]

  • 17. Calmodulin-dependent cyclic AMP phosphodiesterase in liver plasma membranes: stimulated by insulin.
    Smoake JA, Moy GM, Fang B, Solomon SS.
    Arch Biochem Biophys; 1995 Nov 10; 323(2):223-32. PubMed ID: 7487081
    [Abstract] [Full Text] [Related]

  • 18. Cyclic AMP-mediated regulation of vascular smooth muscle cell cyclic AMP phosphodiesterase activity.
    Rose RJ, Liu H, Palmer D, Maurice DH.
    Br J Pharmacol; 1997 Sep 10; 122(2):233-40. PubMed ID: 9313930
    [Abstract] [Full Text] [Related]

  • 19. delta-Opioid receptor activates cAMP phosphodiesterase activities in neuroblastoma x glioma NG108-15 hybrid cells.
    Law PY, Loh HH.
    Mol Pharmacol; 1993 May 10; 43(5):684-93. PubMed ID: 8388986
    [Abstract] [Full Text] [Related]

  • 20. Insulin-sensitive adenosine 3',5'-cyclic monophosphate phosphodiesterase of hepatocyte plasma membrane.
    Tria E, Scapin S, Cocco C, Luly P.
    Biochim Biophys Acta; 1977 Jan 24; 496(1):77-87. PubMed ID: 189834
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 12.